CSIMarket
 


Concert Pharmaceuticals Inc   (CNCE)
Other Ticker:  
 
 

CNCE's Revenue Growth by Quarter and Year

Concert Pharmaceuticals Inc 's Revenue results by quarter and year




CNCE Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 0.01 0.01 0.01
III Quarter September 0.01 0.54 1.50 0.01
II Quarter June 0.02 32.02 6.39 0.05
I Quarter March 0.00 0.01 0.01 1.01
FY   0.03 32.58 7.91 1.08



CNCE Revenue third quarter 2022 Y/Y Growth Comment
Concert Pharmaceuticals Inc reported drop in Revenue in the third quarter 2022 by -98.52% to $ 0.01 millions, from the same quarter in 2021.
The fall in the third quarter 2022 Concert Pharmaceuticals Inc 's Revenue compares unfavorably to the Company's average Revenue doubling of 61426.51%.

Looking into third quarter 2022 results within Major Pharmaceutical Preparations industry 186 other companies have achieved higher Revenue growth. While Concert Pharmaceuticals Inc ' s Revenue meltdown of -98.52% ranks overall at the positon no. 2849 in the third quarter 2022.




CNCE Revenue ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - 0 % 0 % -
III Quarter September -98.52 % -64 % 14900 % 0 %
II Quarter June -99.94 % 401.1 % 12680 % -
I Quarter March - 0 % -99.01 % -90.36 %
FY   - 311.88 % 632.41 % -

Financial Statements
Concert Pharmaceuticals Inc 's third quarter 2022 Revenue $ 0.01 millions CNCE's Income Statement
Concert Pharmaceuticals Inc 's third quarter 2021 Revenue $ 0.54 millions Quarterly CNCE's Income Statement
New: More CNCE's historic Revenue Growth >>


CNCE Revenue (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - -98.15 % -99.33 % 0 %
III Quarter September -60 % -98.31 % -76.53 % -80 %
II Quarter June - 320100 % 63800 % -95.05 %
I Quarter March - 0 % 0 % -
FY (Year on Year)   - 311.88 % 632.41 % -




Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #187
Healthcare Sector #493
Overall #2849

Revenue Y/Y Growth Statistics
High Average Low
958860 % 61426.51 % -100 %
(Sep 30 2017)   (Mar 31 2022)
Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #187
Healthcare Sector #493
Overall #2849
Revenue Y/Y Growth Statistics
High Average Low
958860 % 61426.51 % -100 %
(Sep 30 2017)   (Mar 31 2022)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Concert Pharmaceuticals Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
958860 % 61426.51 % -100 %
(Sep 30 2017)  


CNCE's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2022 Concert Pharmaceuticals Inc disclosed fall in Revenue from the previous quarter by -60% to $ 0.01 millions, from $ 0.02 millions declared in the previous reporting period.

If you analyse recent shortcoming in the quarter, you must assume, that usually III. Quarter 2022 results occur softer relative to the preciding period, Victoria Evans, an industry insider based in New York mentioned.

Within Major Pharmaceutical Preparations industry 256 other companies have achieved higher Revenue quarter on quarter growth. While Concert Pharmaceuticals Inc 's Revenue growth quarter on quarter, overall rank is 3921.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #257
Healthcare Sector #669
Overall #3921
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #257
Healthcare Sector #669
Overall #3921
Revenue Q/Q Growth Statistics
High Average Low
958860 % 61426.51 % -100 %
(Sep 30 2017)  


CNCE's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2022 Concert Pharmaceuticals Inc realized fall in Revenue from the second quarter by -60% to $ 0.01 millions, from $ 0.02 millions achived a quarter before.

When you evaluate present slump in the III. Quarter 2022, you suppose to assume, that usually III. Quarter Revenue emerge softer in contrast to the preciding period

Within Major Pharmaceutical Preparations industry 256 other companies have achieved higher Revenue quarter on quarter growth. While Concert Pharmaceuticals Inc 's Revenue growth quarter on quarter, overall rank is 3921.


Concert Pharmaceuticals Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 32.58 $ 32.57
Y / Y Revenue Growth (TTM) - - - 312.28 % 311.89 %
Year on Year Revenue Growth Overall Ranking # 92 # 0 # 0 # 45 # 57
Seqeuential Revenue Change (TTM) - - - 0.02 % -2.86 %
Seq. Revenue Growth (TTM) Overall Ranking # 2895 # 0 # 0 # 1977 # 2396




Cumulative Revenue growth Comment
Concert Pharmaceuticals Inc realized trailing twelve months of $ 0 millions, in the Sep 30 2022, compare to Revenue of $ 33 millions a year ago.

Within the Healthcare sector 23 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 92.

Revenue TTM Q/Q Growth Statistics
High Average Low
115942.86 %
11627.07 %
-1459.04 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 144
Healthcare Sector # 24
Overall # 92

Revenue TTM Y/Y Growth Statistics
High Average Low
115942.86 %
11627.07 %
-1459.04 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 144
Sector # 398
S&P 500 # 2895
Cumulative Revenue growth Comment
Concert Pharmaceuticals Inc realized trailing twelve months of $ 0 millions, in the Sep 30 2022, compare to Revenue of $ 33 millions a year ago.

Within the Healthcare sector 23 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 92.

Revenue TTM Q/Q Growth Statistics
High Average Low
115942.86 %
11627.07 %
-1459.04 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 144
Healthcare Sector # 24
Overall # 92

Revenue TTM Y/Y Growth Statistics
High Average Low
115942.86 %
11627.07 %
-1459.04 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 144
Sector # 398
S&P 500 # 2895




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CNCE's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for CNCE's Competitors
Revenue Growth for Concert Pharmaceuticals Inc 's Suppliers
Revenue Growth for CNCE's Customers

You may also want to know
CNCE's Annual Growth Rates CNCE's Profitability Ratios CNCE's Asset Turnover Ratio CNCE's Dividend Growth
CNCE's Roe CNCE's Valuation Ratios CNCE's Financial Strength Ratios CNCE's Dividend Payout Ratio
CNCE's Roa CNCE's Inventory Turnover Ratio CNCE's Growth Rates CNCE's Dividend Comparisons



Companies with similar Revenue fall for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2022
Owens and Minor inc-0.19%$ -0.191 millions
National Research Corporation-0.20%$ -0.201 millions
Livanova Plc-0.24%$ -0.241 millions
Healthcare Services Group Inc -0.27%$ -0.265 millions
Catalent Inc -0.29%$ -0.293 millions
Asensus Surgical Inc -0.31%$ -0.311 millions
Liquidia Corporation-0.43%$ -0.429 millions
Integra Lifesciences Holdings Corp-0.43%$ -0.432 millions
Pediatrix Medical Group Inc -0.62%$ -0.615 millions
China Pharma Holdings Inc -0.64%$ -0.642 millions
Acadia Pharmaceuticals Inc -0.68%$ -0.682 millions
Amgen Inc -0.81%$ -0.805 millions
Syneos Health Inc -0.89%$ -0.891 millions
Hologic Inc-0.93%$ -0.925 millions
Innovage Holding Corp -1.07%$ -1.070 millions
Procyon Corporation-1.20%$ -1.200 millions
Precipio inc -1.38%$ -1.380 millions
Ati Physical Therapy Inc -1.40%$ -1.397 millions
Ocular Therapeutix Inc -1.55%$ -1.547 millions
Alpine Immune Sciences Inc -1.75%$ -1.750 millions
Surgalign Holdings Inc -1.79%$ -1.786 millions
Tenet Healthcare Corp-1.90%$ -1.900 millions
Teleflex Incorporated-1.92%$ -1.923 millions
Novocure Limited-1.95%$ -1.952 millions
Dynatronics Corporation-2.01%$ -2.014 millions
Royalty Pharma Plc-2.10%$ -2.101 millions
National Healthcare Corp-2.13%$ -2.130 millions
Fonar Corporation-2.27%$ -2.271 millions
Psychemedics Corp-2.35%$ -2.353 millions
Escalon Medical Corp -2.63%$ -2.626 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com